The Technion’s story has been intertwined with Israel’s for more than a century, from laying the foundations for a new nation to shaping its future.
An estimated 200 million women suffer the pain of a “forgotten” disease. Endometriosis is, in many cases, triggered by their first period, and it’s likely to stay with them until menopause. It’s a chronic and progressive condition characterized by the growth of tiny lesions in the pelvic cavity. It’s the number one cause of infertility and can spread to other organs, sometimes with fatal consequences. It is, however, widely seen as a neglected disease. The symptoms – painful and heavy periods, pain during or after sex, pain going to the toilet during a period, difficulty getting pregnant – are easily…
Student teams from eLab, Cornell’s student startup accelerator, and Jacobs Technion-Cornell Institute Runway Startup Program at Cornell Tech pitched their innovative ideas at San Francisco’s Autodesk Gallery on March 28. The event brought together Cornell Silicon Valley, eLab, Runway Startups, Entrepreneurship at Cornell and the Student Agencies Foundation to highlight innovation throughout the Cornell community. Cornell Silicon Valley connects alumni in the Bay Area to resources like venture capital, financing, legal services, recruitment and publicity. Ken Rother, managing director of eLab and lecturer in the Cornell S.C. Johnson College of Business, welcomed guests to the showcase and said, “A word…
The Israeli developer of a belt-like device that monitors the health of both a pregnant woman and her fetus has merged with a U.S. firm to create a new combined company. Nuvo’s FDA-cleared device INVU is worn around the belly of the expectant mother and uses central and acoustic sensors to measure fetal movements, fetal heart rate and maternal heart rate. The Tel Aviv-based company has merged with California-headquartered LAMF Global Ventures, and the new entity will retain the Nuvo name and existing operational and management structure. It will also be publicly traded on the NASDAQ Stock Market as NUVO,…
Imagine a lab being able to grow tissue from your own body to replace bone lost through damage or illness, and within a matter of weeks be able to fill the gap so well that once it was healed you would never know it had been there. Israeli medtech company Bonus Biogroup says it has created a way of doing just that – and aims to bring its tissue regeneration innovation to the market in the next couple of years. The company works in the fields of cell therapy and tissue engineering, growing live human tissue in vitro (outside of…
Despite the ongoing war and its effects on Israel’s younger population, an Israeli team won first place at the international robotics competition in Houston, Texas, at the end of April, for the first time in twenty years. This competition is run by a non-profit organization called FIRST which strives to expose students to STEM-related subjects through different robotics competitions. With the support and sponsorship of the Technion – Israel Institute of Technology, FIRST Israel offers children programming from when they are in primary school to when they attend high school through which they can learn about robotics as part of…
Nvidia has agreed to acquire Israeli artificial intelligence (AI) company Deci. According to estimates obtained by Calcalist, the value of the deal is $300 million. In Deci’s last fundraising round in July 2022, it was valued at an estimated $200 million. The acquisition is subject to regulatory approvals and is expected to close during the second quarter. Nvidia confirmed the deal to Calcalist, stating that “NVIDIA’s expertise in AI will be complemented by Deci’s capabilities in NAS, which automates the design of deep learning models to improve performance. Deci’s engineering team has knowledge in NAS, Foundational Models, Inference and in…
It’s not just humans – plants get stressed too. And like the rest of us, when they get stressed they tend to “shut down” and simply not produce. The most common kind, abiotic stress, is from intense heat or cold, prolonged dry spells or unhealthy levels of salinity due to rising sea levels and the intrusion of seawater into agricultural fields. How bad is it? More than 830 million hectares of agricultural land is now overly salty. Heat stress is expected to threaten nearly three-quarters of the world’s food production over the next 20 years, according to the research group Verisk…
Undergoing major gastrointestinal (GI) surgery can be challenging enough for a patient without the worry of a grave yet common aftereffect that requires urgent corrective surgery and a lengthy hospital stay – or worse. Israeli startup Exero Medical has come up with a way of keeping tabs on the surgical site after such a procedure, looking for a localized rupture that has hitherto been extremely difficult to detect. Every year, millions of people undergo surgery in the digestive tract – in most cases, for the removal of a part of the digestive system due to issues such as cancer or diverticulitis, Exero…
An Israeli professor is among 10 international recipients of an award for innovative neurobiological and behavioral research. Prof. Dorit Ben-Shachar from the Technion – Israel Institute of Technology is one of the 10 senior-level scientists to equally share the grant of $1 million from the Brain & Behavior Research Foundation (BBRF). Ben-Shachar aims to target mitochondria (the producers of energy within a cell) with a treatment that can help with biological and behavioral problems in schizophrenia. If successful, it can offer a better understanding of the role of mitochondria in schizophrenia, and potentially a new way of treating the condition.
The bacteria in the gut – known as the microbiome – have in recent years emerged as a focal point of scientific exploration, with their intricate roles in our metabolism, nutrition, and overall health coming into sharp focus. Researchers at the Technion-Israel Institute of Technology in Haifa have now made a discovery that could lead to a better understanding of and treatment for inflammatory bowel diseases (IBD) such as colitis and Crohn’s disease. Over millions of years of co-evolution with humans, gut bacteria have become indispensable for the proper functioning of our immune system. The gut is a constantly changing organ,…
An Israeli foodtech startup that makes milk and other dairy products from mushrooms has partnered with one of America’s biggest biotech companies, Ginkgo Bioworks, to scale-up and produce affordable animal-free non-whey dairy products. Haifa-based ImaginDairy has bioengineered milk protein to create a wide range of dairy products using mushrooms but no cows. Through a process called precision fermentation, ImaginDairy recreates these milk proteins in the lab and can use them to generate any kind of dairy product. The partnership aims to improve cost-effective production of non-whey dairy proteins. Ginkgo will utilize its AI capabilities to create biological systems that reduce the cost of production,…
Globally, there is a persistent shortage of viable organs for transplantation. This unmet need has spurred the development of “engineered organs” — cultivated tissue that mimics the structure and function of livers, hearts, lungs and other vital viscera. While these in-vitro inside parts can be used to fill the gap in organ supply, it’s really hard to supply blood throughout the newly transplanted tissue. To solve this problem, Bonus Biogroup, an Israeli biotechnology company specializing in next-generation tissue regeneration therapies, has developed a method of producing a sophisticated network of artificial blood vessels that will enable reliable blood flow to transplanted artificial organs, drastically…